Simponi approved for ulcerative colitis
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
May 15, 2013
0
0
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
May 15, 2013
0
0
Although some have suggested that patients receiving medication for immune-mediated diseases such as rheumatoid arthritis or psoriasis may be at increased risk of herpes zoster (HZ; shingles) shortly after receipt of the ...
Jul 3, 2012
1
1
A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, has identified five biomarkers that may predict the progression of structural damage in the spine of patients with ...
Jun 6, 2012
0
0
Cervical spine CT examinations are unnecessary for emergency department (ED) patients who are a victim of "simple assault" or who have a "ground-level fall", unless the patient has a condition that predisposes the patient ...
May 3, 2012
0
0
Inflammatory bowel disease is relatively rare in Canadian First Nations people but common in white people, possibly due to different genetic variants, according to a new study in CMAJ (Canadian Medical Association Journal) ...
Apr 10, 2012
0
0
(Medical Xpress) -- A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as ...
Jul 10, 2011
0
0